INTRODUCTION AND OBJECTIVES: Objective: to report the experience in 4 tertiary hospitals with the pre-connected, pre-filled and refillable artificial urinary sphincter (AUS) ZSI 375 PF (Zephyr Surgical Implants, Geneva, CH HOSPITAL STAY: 1-3 days. The device was activated 50 days after surgery on average. Refill was performed in 12 PTS (1-3 times each), median volume 0.4 ml. Nine of these PTS have received ERT (including the patient after HIFU, 75%).
CONTINENCE RATE: 19 PTS dry (67.9%), 7 PTS improved (25%), 2 PTS failed (AUS explantation) (7.1%). Seven PTS with persistent urinary incontinence had prior ERT (p[0.1359) and 3 had prior anti-UI surgeries (p[0.4834).
COMPLICATIONS: Erosion with explantation in 2 PTS with prior RUTI and cervicotomy (Clavien-Dindo IIIb) (7.1%); one patient had prior ERT. Postoperative hydrocele in 1 patient, managed conservatively (Clavien-Dindo I) (3.6%). Another patient required catheterization 48 hours after hospital discharge and cuff opening required surgical exploration (Clavien-Dindo IIIa) (3.6%).
CONCLUSIONS: The refillable AUS ZSI 375 PF is a reliable alternative with good continence results and low complication rate. Although previous ERT might influence the achievement of complete continence after implantation, it is not an absolute contraindication. Careful information should be given to PTS with previous RUTI since they seem to have a higher risk for device infection and explantation. Radiation causes fibrosis, which complicates ureteral dissection; and impairs vascularity, which inhibits ureteral healing. Furthermore, these radiation-induced changes may also make psoas hitch and Boari flap (BF) difficult to perform and prone to necrosis. We report our multiinstitutional experience with robotic ureteral reimplantation (RUR) in patients with RIDUS.
METHODS: We retrospectively reviewed our multi-institutional ureteral reconstruction database to identify patients with RIDUS who underwent RUR at three institutions between 1/2013 and 9/2018. Two major RUR techniques were utilized: end-to-end RUR, which involved transecting the ureter and anastomosing the ureteral end to the bladder; and side-to-side RUR, which involved incising healthy ureter medially above the level of the stricture and anastomosing the medial side of the non-transected ureter to the bladder. A psoas hitch and/or BF were performed, when necessary, to facilitate a tension-free anastomosis. Postoperatively, patients were assessed for: clinical success, the absence of flank pain; and radiological success, the absence of obstruction on imaging.
RESULTS: A total of 15 patients underwent 16 RUR. An end-toend RUR was performed in 10/15 (66.7%) cases, while a side-to-side RUR was performed in 5/15 (33.3%) cases. The median stricture length was 3 (IQR 2-5) cm. A psoas hitch was used in 8/15 (53.5%) cases, and a psoas hitch and BF were used in 3/15 (20.0%) cases. The median operative time was 180 (IQR 154-222) min, and estimated blood loss was 100 (IQR 50-100) cc. One patient suffered an intraoperative iliac artery injury, which required primary repair. The median length of stay was 2 (IQR 1-2.5) days. There was one major postoperative complication (Clavien >2) in which a urinary leak occurred in a patient who underwent robotic end-to-end reimplantation with psoas hitch and BF. This patient developed necrosis of the BF 2 weeks postoperatively and eventually required supratrigonal cystectomy and ileal conduit formation. At a median follow-up of 9 (IQR 2.5-25) months 15/16 (93.8%) cases were clinically and radiologically successful.
CONCLUSIONS: RUR performed in an end-to-end or side-toside fashion with or without psoas hitch is an effective reconstructive option for RIDUS, and is associated with good intermediate-term outcomes. Despite this, care should be taken when performing a BF in a radiated field.
